Nan Fung Group Holdings as of Dec. 31, 2022
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 42 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 30.6 | $44M | 226k | 196.50 | |
| Illumina (ILMN) | 16.6 | $24M | 119k | 202.20 | |
| Harmony Biosciences Hldgs In (HRMY) | 14.0 | $20M | 369k | 55.10 | |
| Seagen | 4.2 | $6.1M | 47k | 128.51 | |
| Replimune Group (REPL) | 3.5 | $5.2M | 189k | 27.20 | |
| Exscientia Ads (EXAI) | 3.1 | $4.5M | 853k | 5.33 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $4.5M | 114k | 39.43 | |
| Somalogic Class A Com | 2.9 | $4.3M | 1.7M | 2.51 | |
| Chinook Therapeutics | 2.1 | $3.0M | 114k | 26.20 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 2.0 | $2.9M | 494k | 5.90 | |
| Incyte Corporation (INCY) | 1.9 | $2.8M | 34k | 80.32 | |
| Beigene Sponsored Adr (BGNE) | 1.8 | $2.6M | 12k | 219.94 | |
| Iveric Bio | 1.7 | $2.4M | 112k | 21.41 | |
| Eargo | 1.2 | $1.7M | 3.0M | 0.57 | |
| Bolt Biotherapeutics (BOLT) | 1.0 | $1.5M | 1.2M | 1.30 | |
| Aerovate Therapeutics (AVTE) | 1.0 | $1.5M | 51k | 29.30 | |
| Merus N V (MRUS) | 1.0 | $1.5M | 94k | 15.47 | |
| Pacific Biosciences of California (PACB) | 0.8 | $1.1M | 137k | 8.18 | |
| Exelixis (EXEL) | 0.7 | $1.0M | 64k | 16.04 | |
| Entrada Therapeutics (TRDA) | 0.7 | $995k | 74k | 13.52 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $947k | 33k | 29.12 | |
| Galera Therapeutics (GRTX) | 0.6 | $914k | 613k | 1.49 | |
| BioMarin Pharmaceutical (BMRN) | 0.4 | $633k | 6.1k | 103.49 | |
| Dbv Technologies S A Sponsored Adr | 0.4 | $568k | 371k | 1.53 | |
| Fibrogen (FGEN) | 0.4 | $546k | 34k | 16.02 | |
| Travere Therapeutics (TVTX) | 0.4 | $539k | 26k | 21.03 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $532k | 79k | 6.76 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $509k | 4.2k | 122.13 | |
| Biomea Fusion (BMEA) | 0.3 | $506k | 60k | 8.43 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $477k | 30k | 15.92 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $473k | 42k | 11.27 | |
| Affimed Therapeutics B V | 0.3 | $462k | 373k | 1.24 | |
| Argenx Se Sponsored Adr (ARGX) | 0.3 | $421k | 1.1k | 378.83 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $343k | 1.2k | 290.25 | |
| Gitlab Class A Com (GTLB) | 0.2 | $314k | 6.9k | 45.44 | |
| Satsuma Pharmaceuticals Ord | 0.1 | $160k | 178k | 0.90 | |
| Kodiak Sciences (KOD) | 0.1 | $141k | 20k | 7.16 | |
| Abcellera Biologics (ABCL) | 0.1 | $127k | 13k | 10.13 | |
| Nurix Therapeutics (NRIX) | 0.1 | $126k | 12k | 10.98 | |
| Synlogic | 0.0 | $52k | 69k | 0.76 | |
| Cerus Corporation (CERS) | 0.0 | $52k | 14k | 3.65 | |
| Invitae (NVTAQ) | 0.0 | $21k | 11k | 1.86 |
